The neuroendocrine stress response compensates for suppression of insulin secretion by volatile anesthetic agents: An observational study

Abstract

Alterations in perioperative metabolic function, particularly hyperglycemia, are associated with increased post‐operative complications, even in patients without preexisting metabolic abnormalities. Anesthetic medications and the neuroendocrine stress response to surgery may both contribute to altered energy metabolism through impaired glucose and insulin homeostasis but the discrete pathways involved are unclear. Prior human studies, though informative, have been limited by analytic sensitivity or technique, preventing resolution of underlying mechanisms. We hypothesized that general anesthesia with a volatile agent would suppress basal insulin secretion without altering hepatic insulin extraction, and that surgical stress would promote hyperglycemia through gluconeogenesis, lipid oxidation, and insulin resistance. In order to address these hypotheses, we conducted an observational study of subjects undergoing multi‐level lumbar surgery with an inhaled anesthetic agent. We measured circulating glucose, insulin, c‐peptide, and cortisol frequently throughout the perioperative period and analyzed the circulating metabolome in a subset of these samples. We found volatile anesthetic agents suppress basal insulin secretion and uncouple glucose‐stimulated insulin secretion. Following surgical stimulus, this inhibition disappeared and there was gluconeogenesis with selective amino acid metabolism. No robust evidence of lipid metabolism or insulin resistance was observed. These results show that volatile anesthetic agents suppress basal insulin secretion, which results in reduced glucose metabolism. The neuroendocrine stress response to surgery ameliorates the inhibitory effect of the volatile agent on insulin secretion and glucose metabolism, promoting catabolic gluconeogenesis. A better understanding of the complex metabolic interaction between anesthetic medications and surgical stress is needed to inform design of clinical pathways aimed at improving perioperative metabolic function.

Intraoperative dysglycemia among nondiabetic patients undergoing surgeries: A prospective study in the Palestinian hospitals

“…It has been proposed that these factors can in uence stress responses and subsequently can in uence the occurrence of intraoperative dysglycemia [2,3,12,[19][20][21]. These factors can increase neuroendocrine responses, which stimulate the hypothalamic-pituitary-adrenal axis, sympathoadrenal system and proin ammatory cytokines (tumor necrosis factor-α, interleukin (IL)-1 and interleukin (IL)-6) and lead to excessive gluconeogenesis, glycogenolysis and insulin resistance that result in increased glucose levels [3,22,23].…”